Germline sequencing of DNA-damage-repair genes in two hereditary prostate cancer cohorts reveals rare risk-associated variants
View ORCID ProfileGeorgea R. Foley, James R. Marthick, Sionne E. Lucas, Kelsie Raspin, Annette Banks, Janet L. Stanford, Elaine A. Ostrander, Liesel M. FitzGerald, Joanne L. Dickinson
doi: https://doi.org/10.1101/2022.04.11.22273677
Georgea R. Foley
1Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia
BMedRes (Hons)James R. Marthick
1Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia
BSc (Hons)Sionne E. Lucas
1Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia
PhDKelsie Raspin
1Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia
PhDAnnette Banks
1Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia
Janet L. Stanford
2Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., M4-B874, Seattle, WA 98109-1024, USA
MPH, PhDElaine A. Ostrander
3Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, NIH, Bethesda, MD 20892, USA
PhDLiesel M. FitzGerald
1Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia
PhDJoanne L. Dickinson
1Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia
PhDData Availability
The data underlying this study are available in the article and its online supplementary material, or from the corresponding author on reasonable request. The genome and exome sequencing data underlying this article cannot be shared publicly for ethical/privacy reasons.
Posted April 13, 2022.
Germline sequencing of DNA-damage-repair genes in two hereditary prostate cancer cohorts reveals rare risk-associated variants
Georgea R. Foley, James R. Marthick, Sionne E. Lucas, Kelsie Raspin, Annette Banks, Janet L. Stanford, Elaine A. Ostrander, Liesel M. FitzGerald, Joanne L. Dickinson
medRxiv 2022.04.11.22273677; doi: https://doi.org/10.1101/2022.04.11.22273677
Germline sequencing of DNA-damage-repair genes in two hereditary prostate cancer cohorts reveals rare risk-associated variants
Georgea R. Foley, James R. Marthick, Sionne E. Lucas, Kelsie Raspin, Annette Banks, Janet L. Stanford, Elaine A. Ostrander, Liesel M. FitzGerald, Joanne L. Dickinson
medRxiv 2022.04.11.22273677; doi: https://doi.org/10.1101/2022.04.11.22273677
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (202)
- Cardiovascular Medicine (2954)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12766)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4600)
- Geriatric Medicine (420)
- Health Economics (731)
- Health Informatics (2934)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (926)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (471)
- Neurology (4377)
- Nursing (237)
- Nutrition (640)
- Oncology (2277)
- Ophthalmology (648)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1197)
- Primary Care Research (499)
- Public and Global Health (6963)
- Radiology and Imaging (1533)
- Respiratory Medicine (916)
- Rheumatology (441)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (181)